Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-12-11
DOI
10.3389/fnagi.2018.00409
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Decade of Blood Biomarkers for Alzheimer’s Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication
- (2018) Liu Shi et al. JOURNAL OF ALZHEIMERS DISEASE
- Amsterdam Dementia Cohort: Performing Research to Optimize Care
- (2018) Wiesje M. van der Flier et al. JOURNAL OF ALZHEIMERS DISEASE
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment
- (2018) David A. Wolk et al. JAMA Neurology
- Apolipoprotein C-III is an Amyloid-β-Binding Protein and an Early Marker for Alzheimer's Disease
- (2018) Yao-Hsiang Shih et al. JOURNAL OF ALZHEIMERS DISEASE
- Optimizing Patient Care and Research: The Amsterdam Dementia Cohort
- (2018) Wiesje M. van der Flier et al. JOURNAL OF ALZHEIMERS DISEASE
- Circulating miRNAs as Potential Biomarkers in Alzheimer's Disease
- (2018) Daniela Galimberti et al. JOURNAL OF ALZHEIMERS DISEASE
- Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer’s Disease in Non-Demented Elderly
- (2017) Rosalinde E.R. Slot et al. JOURNAL OF ALZHEIMERS DISEASE
- Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
- (2017) Nour K. Majbour et al. Scientific Reports
- Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly
- (2016) Sarah Westwood et al. JOURNAL OF ALZHEIMERS DISEASE
- Low levels of ficolin-3 are associated with diabetic peripheral neuropathy
- (2015) Xiaoyan Zhang et al. ACTA DIABETOLOGICA
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
- (2015) Daniel Alcolea et al. NEUROLOGY
- Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
- (2015) Sebastian Palmqvist et al. NEUROLOGY
- DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes
- (2015) J. Pinero et al. Database-The Journal of Biological Databases and Curation
- Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease
- (2015) Jon B. Toledo et al. JAMA Neurology
- Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology
- (2015) Alison L. Baird et al. Frontiers in Neurology
- Plasma proteins predict conversion to dementia from prodromal disease
- (2014) Abdul Hye et al. Alzheimers & Dementia
- Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology
- (2014) Martina Sattlecker et al. Alzheimers & Dementia
- Bone Loss and Osteoporosis are Associated with Conversion from Mild Cognitive Impairment to Alzheimer’s Disease
- (2014) Rui Zhou et al. Current Alzheimer Research
- Protein-Based Biomarkers in Cerebrospinal Fluid and Blood for Alzheimer’s Disease
- (2014) Yongyao Fu et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- STRING v10: protein–protein interaction networks, integrated over the tree of life
- (2014) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid- 1-42 and Proteins as Alzheimer Disease Biomarkers
- (2013) J.-H. Kang et al. CLINICAL CHEMISTRY
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- The NHGRI GWAS Catalog, a curated resource of SNP-trait associations
- (2013) Danielle Welter et al. NUCLEIC ACIDS RESEARCH
- Human L-Ficolin (Ficolin-2) and Its Clinical Significance
- (2012) David C. Kilpatrick et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
- (2012) Konrad Talbot et al. JOURNAL OF CLINICAL INVESTIGATION
- Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
- (2012) W. T. Hu et al. NEUROLOGY
- Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals
- (2012) Fei Song et al. PLoS One
- Plasma Based Markers of [11C] PiB-PET Brain Amyloid Burden
- (2012) Steven John Kiddle et al. PLoS One
- Low serum levels of the innate immune component ficolin-3 is associated with insulin resistance and predicts the development of type 2 diabetes
- (2012) Haibing Chen et al. Journal of Molecular Cell Biology
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Serum Levels of Pregnancy Zone Protein are Elevated in Presymptomatic Alzheimer’s Disease
- (2011) Linda IJsselstijn et al. JOURNAL OF PROTEOME RESEARCH
- Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
- (2010) Madhav Thambisetty et al. ARCHIVES OF GENERAL PSYCHIATRY
- Blood-based biomarkers of Alzheimer’s disease: challenging but feasible
- (2010) Madhav Thambisetty et al. Biomarkers in Medicine
- Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease
- (2010) Kelly R. Bales NEUROPHARMACOLOGY
- Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
- (2010) Lesley Jones et al. PLoS One
- Amyloid- (1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
- (2009) C. Mulder et al. CLINICAL CHEMISTRY
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
- (2009) C. E. Teunissen et al. NEUROLOGY
- Human apolipoprotein A–I binds amyloid-β and prevents Aβ-induced neurotoxicity
- (2008) Andréa C. Paula-Lima et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Localized-Statistical Quantification of Human Serum Proteome Associated with Type 2 Diabetes
- (2008) Rong-Xia Li et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now